Study: Patients with specific oncogenic rearrangements of ALK gene show greater response to new therapy

Links shared publicly online about this topic.

1,460
total visits

Study: Patients with specific oncogenic rearrangements of ALK gene show greater response to new therapy

Results of a new study in non-small cell lung cancer showed that patients with specific oncogenic rearrangements of the anaplastic lymphoma kinase (ALK) gene within the short arm of chromosome 2 of their tumors had a much greater response to a new therapy - an ALK-inhibitor.

View full resource at news-medical.net

Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma, Lung, Genes